CN113491751A - A medicated core for preventing influenza, Chinese medicinal composition, sachet, medicated bath bag, foot bath bag, and preparation method thereof - Google Patents
A medicated core for preventing influenza, Chinese medicinal composition, sachet, medicated bath bag, foot bath bag, and preparation method thereof Download PDFInfo
- Publication number
- CN113491751A CN113491751A CN202010252571.XA CN202010252571A CN113491751A CN 113491751 A CN113491751 A CN 113491751A CN 202010252571 A CN202010252571 A CN 202010252571A CN 113491751 A CN113491751 A CN 113491751A
- Authority
- CN
- China
- Prior art keywords
- parts
- sachet
- core
- influenza
- moxa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug core for preventing influenza, a traditional Chinese medicine composition, a sachet and a preparation method thereof, wherein the drug core is prepared from moxa, herba schizonepetae, rhizoma acori graminei, pogostemon cablin, perilla leaves, raw liquorice, eupatorium, rhizoma ligustici wallichii, cinnamon, radix angelicae, mint, clove, rosewood heart wood, nardostachyos root and rhizome, rhizoma kaempferiae and rhizoma atractylodis. The composition has the characteristics of no toxic or side effect, convenient use, obvious prevention effect and the like, has obvious effect and is worthy of daily popularization and use.
Description
Technical Field
The invention relates to a traditional Chinese medicine composition sachet for preventing influenza and a preparation method thereof.
Background
In recent years, the academic idea of 'preventive treatment of disease' of traditional Chinese medicine is highly regarded by the medical field, and with the improvement of the living standard of people, the health care consciousness is enhanced, and the traditional Chinese medicine sachet gradually becomes the popular trend. The traditional Chinese medicine sachet has a long history, the sachet is used as a method for preventing and treating diseases in the ancient Chinese medical history, the ancient Chinese is called as the crown therapy, and the influence of the sachet is far from the theory that the sachet is worn by a vanilla bag and is not afraid of five insect pests. Wearing a sachet is a folk-custom, but also a method for preventing epidemic diseases. The sachet is usually made from aromatic Chinese herbal medicines with resuscitation effect, such as rhizoma Atractylodis, rhizoma Kaempferiae, radix Angelicae Dahuricae, rhizoma Acori Calami, rhizoma Ligustici Chuanxiong, rhizoma Cyperi, etc., which have effects of eliminating turbid pathogen and dispelling plague, and contains strong volatile substances. Modern researches believe that the Chinese herbal medicine in the traditional Chinese medicine sachet emits rich fragrance to form a high-concentration microenvironment around a human body, so that on one hand, the traditional Chinese medicine sachet has a certain resistance effect on bacteria and viruses in the environment, and on the other hand, the traditional Chinese medicine ingredients enter the human body through a respiratory tract, and the aromatic odor can excite a nervous system and stimulate nasal mucosa, so that the content of antibody-secretory immunoglobulin on the nasal mucosa is increased, the immune system of the organism is continuously stimulated, the generation of the antibody is promoted, the traditional Chinese medicine sachet has the effect of inhibiting the growth of various pathogenic bacteria, and the disease resistance of the body can be improved. Meanwhile, after the drug odor molecules are absorbed by the human body, the digestive gland activity can be promoted, and secretion is increased, so that the activity of digestive enzyme is improved, the appetite is enhanced, and the effect of building the body is achieved. In general, the traditional Chinese medicine sachet has specific drug effects by the drugs filled in the traditional Chinese medicine sachet, and the traditional Chinese medicine sachet is used for playing a corresponding role in preventing or treating diseases for a user by utilizing the volatile effect of the drugs, so that the traditional Chinese medicine sachet is convenient for the user to wear, the volume of the sachet is generally not too large, and the curative effect of the traditional Chinese medicine sachet is optimal in a limited space of the sachet, which is a problem to be considered urgently.
Disclosure of Invention
The inventor of the present invention has made intensive studies on the technology of traditional Chinese medicine sachets, and the traditional Chinese medicine sachets are generally worn on the person, or placed indoors or in a certain space such as a car, etc., and the volume of the traditional Chinese medicine sachets is relatively inadmissible, but in a limited space, the traditional Chinese medicine sachets have the effect of preventing and treating certain diseases, the medicine amount released in the surrounding environment needs to reach a certain high concentration, and only when the medicine concentration reaches a certain effect, the traditional Chinese medicine sachets can have a certain resistance effect on bacteria and viruses in the environment, and the inventor finds that: on one hand, the drug effect can be improved by increasing the dosage of the active ingredients, but the dosage is limited by the size of the sachet, and on the other hand, the contact area between the drug and the air is increased in the limited space of the sachet, so that more active ingredients can be released by the drug in the same time. Based on the two points, the inventor develops a traditional Chinese medicine composition sachet capable of effectively preventing influenza through numerous tests.
The invention discloses a drug core for effectively preventing influenza.
The second purpose of the invention is to disclose a traditional Chinese medicine composition for effectively preventing influenza.
The third purpose of the invention is to disclose a sachet, a medicated bath bag and a foot bath bag which can effectively prevent influenza.
The fourth purpose of the invention is to disclose a preparation method of the sachet for preventing influenza.
The detailed technical scheme of the invention is as follows: the drug core for preventing influenza comprises moxa, raw licorice powder, antibacterial drugs, poison-inhibiting drugs, aromatic drugs and the like, wherein the moxa is a drug core framework, and the raw licorice powder, the antibacterial drugs, the poison-inhibiting drugs and the aromatic drugs are uniformly mixed and dispersed in the moxa in the drug core.
The inventor researches and discovers that the antibacterial drugs, the poison inhibiting drugs and the aromatic drugs in the drug core for preventing the influenza comprise: moxa, herba schizonepetae, rhizoma acori graminei, pogostemon cablin, perilla leaves, raw liquorice, eupatorium, rhizoma ligustici wallichii, rhizoma atractylodis, cinnamon, radix angelicae, mint, clove, rosewood heart wood, nardostachyos root and rhizoma kaempferiae.
The influenza prevention drug core is preferably selected from the following drugs in parts by weight: 15-25 parts of moxa, 5-15 parts of schizonepeta, 5-15 parts of rhizoma acori graminei, 5-15 parts of pogostemon cablin, 5-15 parts of perilla leaves, 5-15 parts of raw liquorice, 5-15 parts of eupatorium, 5-15 parts of ligusticum wallichii, 5-15 parts of rhizoma atractylodis, 3-8 parts of cinnamon, 3-8 parts of radix angelicae, 3-8 parts of mint, 3-8 parts of clove, 3-8 parts of dalbergia wood, 3-8 parts of nardostachyos root and rhizome and 3-8 parts of rhizoma kaempferiae.
The influenza prevention drug core is preferably prepared from the following drugs in parts by weight: 20 parts of moxa, 10 parts of schizonepeta, 10 parts of rhizoma acori graminei, 10 parts of pogostemon cablin, 10 parts of perilla leaves, 10 parts of raw liquorice, 10 parts of eupatorium, 10 parts of ligusticum wallichii, 10 parts of rhizoma atractylodis, 5 parts of cinnamon, 5 parts of radix angelicae, 5 parts of mint, 5 parts of clove, 5 parts of dalbergia wood, 5 parts of nardostachyos root and rhizome and 5 parts of rhizoma kaempferiae.
The inventor researches and discovers that the traditional Chinese medicines in the drug core for preventing the influenza can also be used as a traditional Chinese medicine composition for preventing the influenza for general external use
The above medicated cores for preventing influenza can be used in medicated bath bag and foot bath bag for preventing influenza.
The influenza prevention medicine cores can be used for external use influenza prevention sachets.
According to the preparation method of the externally-used influenza prevention sachet, except for the fact that the moxa is directly arranged on the medicine core in the influenza prevention medicine core, other medicines are mixed in a powder form, the medicines and the moxa are filled into the medicine core shell, the medicine core shell is sealed, the medicines are mixed in the medicine core, the medicine powder is filled and distributed in gaps of the moxa, the material gap interval mu of the medicine core shell is smaller, the volatilization particle size mu of effective components of the medicines is smaller than the particle size of medicine powder particles, and the mu is preferably larger in the interval.
The invention achieves the technical effects that:
the invention relates to a drug core for preventing influenza, which can be realized by an antibacterial and antiviral drug, and aims to reduce toxic and side effects. The moxa is tendons and bones, namely the moxa is filled in the medicine core, so that the internal space of the medicine core is maximized, the internal space structure of the medicine core is supported, and meanwhile, a honeycomb-shaped intercommunicating gap structure is formed in the medicine core, so that the air in the medicine core is smooth; the use of raw licorice root in the present invention effectively reduces the odor impact of various drugs such as antibacterial drugs, poison-suppressing drugs and aromatic drugs when they are simultaneously released at high concentration, as if the qi in the human body drives the blood to flow smoothly and powerfully in the human body. The drug can be released at high concentration, and the smell is kept mild. Other antibacterial drugs, poison-inhibiting drugs, aromatic drugs, etc. are used as the blood core, i.e., the drug core needs to have certain functionality, while the antibacterial drugs, poison-inhibiting drugs, aromatic drugs, etc. in the present invention realize the function.
In the invention: moxa, herba schizonepetae, rhizoma acori graminei, pogostemon cablin, perilla leaves, raw liquorice, eupatorium, ligusticum wallichii, rhizoma atractylodis, cinnamon, radix angelicae, mint, clove, rosewood heart wood, nardostachys root and rhizoma kaempferiae, and the technical effects of the traditional Chinese medicine composition, the medicine core and the sachet for preventing influenza are analyzed as follows: the moxa, the grassleaf sweelflag rhizome, the cablin potchouli herb, the eupatorium fortunei, the szechuan lovage rhizome, the swordlike atractylodes rhizome, the dahurian angelica root and the clove are taken as main drug effects, and other drugs are used for blending fragrance on one hand and assisting in antibiosis and antivirus on the other hand:
moxa: the moxa made of new moxa is used in the invention, on one hand, the moxa plays a leading role in the curative effect in the invention; in addition, the space structure for building the medicine core is beneficial to the release of other medicine properties in the medicine core, and ensures that each medicine in the medicine core can be continuously released in a stable release amount range; in addition, the property of dry heat of Xinai is taken to enhance the action of this recipe to dry dampness.
Herba schizonepetae and perilla leaves: both of them are wind-dispelling herbs and Schizonepeta tenuifolia, which have mild smell and pungent and warm taste, can dispel wind-cold, pungent but not intense, warm but not dry, relieve exterior pathogen and virus, and are indicated for common cold. Perilla leaf, is effective in expelling pathogenic cold, soothing middle energizer and promoting qi circulation, with strong fragrance and action of opening skin and hair, and purging lung-qi to open the striae. The two medicines are mutually reinforced, so that the effects of expelling wind and removing cold are enhanced, and the cold can be effectively prevented.
Grass-leaved sweetflag rhizome and dahurian angelica root: in addition to the respective drug effects, the invention further highlights the functions of the two drugs of promoting the restoration of consciousness and enhancing the antiviral and antibacterial abilities of the respiratory tract.
Patchouli and eupatorium: the two ingredients are used for mutual reinforcement, and the dampness resolving effect of the medicine core of the invention is enhanced besides the respective medicine effects.
Rhizoma ligustici wallichii and cinnamon: the combination of the ligusticum wallichii and the cinnamon is a classic formula of traditional Chinese medicine, namely ligusticum wallichii and cinnamon decoction, is from secret collection of orchid rooms, has the effects of dispelling wind, cold and dampness, and promoting blood circulation to arrest pain, and the combination of the ligusticum wallichii and the cinnamon and other medicines emphasizes the effect of taking the two medicines to dissipate cold and dredge channels and collaterals to assist the curative effect of moxa.
Mint: the traditional Chinese medicine composition has the effects of dispelling melancholy, and effectively combining the excessive dryness-heat properties of the folium artemisiae argyi, the rhizoma atractylodis, the radix angelicae, the moxa and the cinnamon in the formula.
Clove, dalbergia wood, nardostachys root and rhizome, and rhizoma kaempferiae: in the invention, the volatilization of the antibacterial and antiviral effects is utilized in addition to the antibacterial and antiviral effects, so that the efficacy of releasing the drug properties of other medicines in the recipe is assisted, and the nardostachys chinensis and rhizoma kaempferiae have the effect of eliminating dampness.
Rhizoma atractylodis: the invention enhances the dampness resolving effect, and dispels wind and relieves exterior syndrome. In addition, rhizoma atractylodis can activate spleen and strengthen transportation, and can be used for relieving the symptoms of anorexia caused by damp obstruction of middle-jiao.
Raw licorice root: on one hand, the drug core has certain aromatic odor, and can play the role of the aroma when being used in the drug core; on the other hand, the functions are as follows: the invention uses a large amount of medicines with odor, particularly strong odor, and the odor of the medicines can be accepted when the medicines are used singly, but the medicines are arranged in the same sachet, and the odor after mixing is more pungent.
Detailed Description
The following examples may help those skilled in the art to more fully understand the present invention. But not limiting the invention in any way, the number of parts in the examples of the invention can be chosen to be grams or kilograms or other units of mass according to the actual requirements.
Example 1: preparation of small sachet for children
Content of sachet drug core: 20 parts of moxa, 10 parts of schizonepeta, 10 parts of rhizoma acori graminei, 10 parts of pogostemon cablin, 10 parts of perilla leaves, 10 parts of raw liquorice, 10 parts of eupatorium, 10 parts of ligusticum wallichii, 10 parts of rhizoma atractylodis, 5 parts of cinnamon, 5 parts of radix angelicae, 5 parts of mint, 5 parts of clove, 5 parts of dalbergia wood, 5 parts of nard and 5 parts of rhizoma kaempferiae
[ PREPARATION METHOD ] removing moxa, pulverizing into 30-50 mesh, sieving, mixing with moxa uniformly, filling into medicine core per 10g, selecting non-woven fabric with pore diameter smaller than 50 mesh, sealing, filling into sachet made of air-permeable fabric, and storing the medicine core with air-tight seal if it is not used in time.
Example 2: preparation of adult big sachet
Content of sachet drug core: 20 parts of moxa, 10 parts of schizonepeta, 10 parts of rhizoma acori graminei, 10 parts of pogostemon cablin, 10 parts of perilla leaves, 10 parts of raw liquorice, 10 parts of eupatorium, 10 parts of ligusticum wallichii, 10 parts of rhizoma atractylodis, 5 parts of cinnamon, 5 parts of radix angelicae, 5 parts of mint, 5 parts of clove, 5 parts of dalbergia wood, 5 parts of nard and 5 parts of rhizoma kaempferiae
[ PREPARATION METHOD ] removing moxa, pulverizing into 30-50 mesh, sieving, mixing with moxa uniformly, filling into medicine core per 30g, selecting non-woven fabric with pore diameter smaller than 50 mesh, sealing, filling into sachet made of air-permeable fabric, and storing the medicine core with air-tight seal if it is not used in time.
Example 3: preparation of medicated bath bag
The content of the drug core is as follows: 20 parts of moxa, 10 parts of schizonepeta, 10 parts of rhizoma acori graminei, 10 parts of pogostemon cablin, 10 parts of perilla leaves, 10 parts of raw liquorice, 10 parts of eupatorium, 10 parts of ligusticum wallichii, 10 parts of rhizoma atractylodis, 5 parts of cinnamon, 5 parts of radix angelicae, 5 parts of mint, 5 parts of clove, 5 parts of dalbergia wood, 5 parts of nard and 5 parts of rhizoma kaempferiae
[ PREPARATION METHOD ] removing moxa, pulverizing into 30-50 mesh, sieving, mixing with moxa uniformly, filling into medicine core per 45g, selecting non-woven fabric with pore diameter smaller than 50 mesh, sealing, hermetically storing the medicine core, directly unsealing, and placing into bath water.
Example 4: influenza prevention experiment for children
Materials: the sachet of example 1.
The use method comprises the following steps: worn on the chest and sniffed.
Time: month 3 and month 4 of 2019.
Case selection: kindergarten children, age interval: age 4 6 months-age 5 6 months. The eight classes total 158 children, each 20 + -2, and are divided into two groups, four classes, respectively, control group, experimental group, and 79 children.
Control group: as usual, the sachet was not worn.
Experimental groups: go up to learn the period and wear the sachet, early go up to the kindergarten and wear the sachet, give the mr sealed save when putting school, continue to wear to the kindergarten the next day, division is fixed a holiday, changes new sachet after 5 days are worn in succession to every sachet, and every child actually wears: a first sachet 3.4-3.8; a second sachet 3.11-3.15; a third sachet 3.18-3.22; a fourth sachet 3.25-3.29; a fifth sachet 4.1-4.4; a sixth sachet 4.8-4.12; a seventh sachet 4.15-4.19; the eighth sachet was 4.22-4.26 for a total of 39 days.
And (3) data statistics:
TABLE 1 data statistics of influenza infants in control and experimental groups
| Group of | Number of persons actually participating in the experiment | 3.4. 4.26. (including during home) number of people with influenza | Prevalence rate |
| Control group | 69 name (I) | 42 name of | 60.9% |
| Experimental group | 71 name of | 9 name of | 12.7% |
Description of the drawings:
description of time selection: the children are adapted to the life of the kindergarten after the children begin to learn one week after influenza outbreak in spring in 3 and 4 months.
Case selection instructions: kindergarten children belong to influenza gathering outbreak crowd, many kindergartens can disinfect the classroom after leaving school or 1 hour in advance before the early children enter the garden, then ventilate the back, meet children, but this can only get rid of the residual bacterial virus in the classroom, and as long as have a child on class to catch a cold, the children who sit beside it or lie beside him in the noon break down in the school day generally can't avoid all being infected. The middle class children are selected, and compared with the children who just enter the garden, the general emotion has a certain influence factor on diseases, and the children who are on duty are frequent, so that the statistical significance is low. The relative degree of cooperation of big and small friends is not as good as that of middle school.
The actual number of participants in the control group and the treatment group is as follows: the children who can not come to the kindergarten due to the fact that the accident or other diseases except flu continue for more than 2 days are removed from the original plan number, wherein 69 actual participants of the control group and 71 actual participants of the experimental group are selected.
Example 5: low resistance adult influenza prevention experiment
Materials: the sachet of example 2.
The use method comprises the following steps: hanging beside the body, such as a taxi driver hanging in a car, office staff hanging on an office desk, etc., requires that the distance between the mouth and the nose is preferably within 0.5 m and can not exceed 1 m, or wearing in front of the chest.
Time: the patient selection time period is 6 months from 2018 to 6 months from 2019, each person continuously wears the sachets for 6 months, each sachet is replaced every 10 days, the sachets are not less than 8 hours per day, 24 hours are recommended to be carried about, each user wears the sachet for 1 month to feed back information, the medicine is stopped at the 7 th month, and the patient returns to visit after stopping the medicine for 1 month.
Case selection: in the period from 6 months 2018 to 6 months 2019, there are 392 total cases of low-resistance adults treated by flu in outpatient service (in the present embodiment, the low-resistance adults have flu infection once or more per month or every two months), and the age interval: between 23 and 87 years of age.
The influenza indexes are as follows: one or two or three or all of fever, cough, headache and general weakness
Influenza prevention data statistics are presented in table 2
| Time | Has a symptom | Has two symptoms | Has three symptoms | All symptoms are | Total up to | Testing the number of feedback people | Percentage of |
| The first month | 56 | 34 | 18 | 12 | 120 | 387 | 31.01% |
| The second month | 21 | 16 | 3 | 1 | 41 | 369 | 11.11% |
| The third month | 13 | 5 | 0 | 0 | 18 | 354 | 5.08% |
| The fourth month | 3 | 0 | 0 | 0 | 3 | 341 | 0.88% |
| The fifth month | 1 | 0 | 0 | 0 | 1 | 337 | 0.30% |
| The sixth month | 0 | 0 | 0 | 0 | 0 | 335 | 0.00% |
| The seventh month | 0 | 0 | 0 | 0 | 0 | 334 | 0.00% |
Description of the drawings: the number of the original cases is 392 in total, 387 cases exist in the first month of the permanent wearers, 335 cases exist in the permanent wearers for 6 months, 32 cases exist in the permanent wearers, and the cases include: the sachet is not perceived to be smelled, is forgotten to be worn continuously, is not considered to be worn when seeing the effect, is lost and is not connected in individual cases, and the like.
Example 6: comparison test of total volatile organic compound release concentration of sachet
The experimental instrument: MEF-500
Temperature: a relatively closed space of 14 ℃ and a relatively open space of 13-15 DEG C
Humidity: 42 to 45 percent
Measuring point time: each sachet was measured at the same time every day for 10 days
The determination method comprises the following steps: measuring the surface of the sachet after the sachet is placed in the relatively closed space for 1 hour under the state that the air does not flow; the relatively open space simulates the use environment of a common user in an office, and the surface of the sachet is measured, wherein the surface comprises data of three states, namely a state, a state and a state, wherein the data are provided beside the person to walk frequently and are relatively static. Each sachet was in a simulated office environment at all times except for being placed in a relatively enclosed space for 1 hour per day.
Test materials:
control group: example 2 the adult uses 20 large sachets of 30g, and the moxa in the medicine in the sachets is replaced by folium Artemisiae Argyi powder
Test groups: example 2 adult human 30g of large sachets of 20
TABLE 3 Tvoc (in mg/m) released by each sachet after each group of sachets has been placed in a relatively closed space for 1 hour a day3) Mean value recording table
| Group of | Day one | The next day | The third day | The fourth day | The fifth day | Day six | The seventh day | Day eight | The ninth day | The tenth day |
| Control group | 2.01 | 1.76 | 1.53 | 1.09 | 0.38 | 0.12 | 0.03 | ＜0.01 | ＜0.01 | ＜0.01 |
| Experimental group | 1.98 | 1.85 | 1.77 | 1.72 | 1.65 | 1.61 | 1.58 | 1.53 | 1.47 | 1.44 |
TABLE 4 Tvoc released in three states per day (in mg/m) for each group of sachets3) Mean value recording table
Description of the drawings:
environment: the environment of each sachet was the same in both groups, as measured daily at TVOC values, including: temperature, humidity, simulated office personnel flow rate.
The data source is as follows: the above data were obtained by averaging the TVOC values measured at each condition per day for 20 sachets per group.
It will be apparent to those skilled in the art that various changes and modifications can be made in the above embodiments without departing from the scope and spirit of the invention, and it is intended that all simple changes, equivalents and modifications made to the above embodiments in accordance with the technical spirit of the invention shall fall within the scope of the invention. And the invention is not limited to the example embodiments set forth in the description.
Claims (9)
1. A medicated core for preventing influenza comprises folium Artemisiae Argyi, Glycyrrhrizae radix powder, antibacterial agent, poison inhibiting agent, and aromatic agent, wherein the folium Artemisiae Argyi is core skeleton, and Glycyrrhrizae radix powder, antibacterial agent, poison inhibiting agent, and aromatic agent are uniformly mixed and dispersed in folium Artemisiae Argyi in the core.
2. The drug core for preventing influenza as claimed in claim 1, wherein the moxa, the licorice powder, the antibacterial agent, the poison-suppressing agent, and the aromatic agent comprise moxa, schizonepeta, grassleaf sweelflag rhizome, patchouli, perilla leaf, licorice, eupatorium, chuanxiong rhizome, atractylodes rhizome, cinnamon bark, dahurian angelica root, peppermint, clove, dalbergia wood, nardostachyos root and kaempferia galangal.
3. The drug core for preventing influenza of claim 2, which is characterized in that the weight parts of the drugs are as follows: 15-25 parts of moxa, 5-15 parts of schizonepeta, 5-15 parts of rhizoma acori graminei, 5-15 parts of pogostemon cablin, 5-15 parts of perilla leaves, 5-15 parts of raw liquorice, 5-15 parts of eupatorium, 5-15 parts of ligusticum wallichii, 5-15 parts of rhizoma atractylodis, 3-8 parts of cinnamon, 3-8 parts of radix angelicae, 3-8 parts of mint, 3-8 parts of clove, 3-8 parts of dalbergia wood, 3-8 parts of nardostachyos root and rhizome and 3-8 parts of rhizoma kaempferiae.
4. The drug core for preventing influenza of claim 3, which is characterized in that the weight parts of the drugs are as follows: 20 parts of moxa, 10 parts of schizonepeta, 10 parts of rhizoma acori graminei, 10 parts of pogostemon cablin, 10 parts of perilla leaves, 10 parts of raw liquorice, 10 parts of eupatorium, 10 parts of ligusticum wallichii, 10 parts of rhizoma atractylodis, 5 parts of cinnamon, 5 parts of radix angelicae, 5 parts of mint, 5 parts of clove, 5 parts of dalbergia wood, 5 parts of nardostachyos root and rhizome and 5 parts of rhizoma kaempferiae.
5. A topical Chinese medicinal composition for preventing influenza, which comprises the medicine in the core for preventing influenza according to any one of claims 1-4.
6. A medicated bath bag or foot bath bag for preventing influenza by external application, which comprises the influenza preventing drug core of any one of claims 1-4.
7. A topical influenza prevention sachet comprising an influenza prevention core as claimed in any of claims 1 to 4.
8. The method for preparing a topical sachet for preventing influenza of claim 7, wherein the influenza preventing drug core is prepared by mixing other drugs except moxa in powder form, filling the powder with moxa into the drug core case, sealing, mixing the drugs in the drug core to make the powder filled and distributed in the gaps between moxa, storing the drug core in a sealed manner, unsealing when using, and placing into the sachet case.
9. The preparation method of the externally-applied sachet for preventing influenza according to claim 8, wherein the drug core shell material gap interval is mu, and the volatilization particle size of the active ingredients of the drug is less than mu and the particle size of the drug powder particles is less than mu.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010252571.XA CN113491751A (en) | 2020-04-02 | 2020-04-02 | A medicated core for preventing influenza, Chinese medicinal composition, sachet, medicated bath bag, foot bath bag, and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010252571.XA CN113491751A (en) | 2020-04-02 | 2020-04-02 | A medicated core for preventing influenza, Chinese medicinal composition, sachet, medicated bath bag, foot bath bag, and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113491751A true CN113491751A (en) | 2021-10-12 |
Family
ID=77994214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010252571.XA Pending CN113491751A (en) | 2020-04-02 | 2020-04-02 | A medicated core for preventing influenza, Chinese medicinal composition, sachet, medicated bath bag, foot bath bag, and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113491751A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721618A (en) * | 2009-11-24 | 2010-06-09 | 中国人民解放军第二军医大学 | External Chinese medicinal health-care bag for dispelling filth and preventing and treating influenza |
| CN102349991A (en) * | 2011-05-29 | 2012-02-15 | 王红芳 | Composition for killing virus and preventing influenza and cold prevention plaster prepared by composition |
| CN105077868A (en) * | 2014-05-12 | 2015-11-25 | 广西农善堂养生保健科技有限公司 | Sachet capable of adjusting immunity and preparation method of sachet |
| CN105477218A (en) * | 2015-12-11 | 2016-04-13 | 中国人民解放军第二军医大学 | Traditional Chinese medicine composition for preventing influenza and application thereof |
| CN105560663A (en) * | 2015-12-29 | 2016-05-11 | 中国人民解放军第三〇二医院 | Traditional Chinese medicinal composition for treating diseases caused by exogenous seasonal pathogenic factors and preparation method thereof |
| CN106177709A (en) * | 2016-08-19 | 2016-12-07 | 华巧波 | A kind of preventing cold sachet and preparation method thereof |
| CN108355026A (en) * | 2018-05-18 | 2018-08-03 | 王轲甫 | A kind of Chinese medicine sachet of flu-prevention |
| CN110721254A (en) * | 2018-07-17 | 2020-01-24 | 黄俪丽 | Plant source fragrant medicine bag and preparation method thereof |
| CN111358904A (en) * | 2020-03-24 | 2020-07-03 | 荆楚理工学院 | Traditional Chinese medicine electric aromatherapy liquid with epidemic prevention function and preparation method and application thereof |
-
2020
- 2020-04-02 CN CN202010252571.XA patent/CN113491751A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101721618A (en) * | 2009-11-24 | 2010-06-09 | 中国人民解放军第二军医大学 | External Chinese medicinal health-care bag for dispelling filth and preventing and treating influenza |
| CN102349991A (en) * | 2011-05-29 | 2012-02-15 | 王红芳 | Composition for killing virus and preventing influenza and cold prevention plaster prepared by composition |
| CN105077868A (en) * | 2014-05-12 | 2015-11-25 | 广西农善堂养生保健科技有限公司 | Sachet capable of adjusting immunity and preparation method of sachet |
| CN105477218A (en) * | 2015-12-11 | 2016-04-13 | 中国人民解放军第二军医大学 | Traditional Chinese medicine composition for preventing influenza and application thereof |
| CN105560663A (en) * | 2015-12-29 | 2016-05-11 | 中国人民解放军第三〇二医院 | Traditional Chinese medicinal composition for treating diseases caused by exogenous seasonal pathogenic factors and preparation method thereof |
| CN106177709A (en) * | 2016-08-19 | 2016-12-07 | 华巧波 | A kind of preventing cold sachet and preparation method thereof |
| CN108355026A (en) * | 2018-05-18 | 2018-08-03 | 王轲甫 | A kind of Chinese medicine sachet of flu-prevention |
| CN110721254A (en) * | 2018-07-17 | 2020-01-24 | 黄俪丽 | Plant source fragrant medicine bag and preparation method thereof |
| CN111358904A (en) * | 2020-03-24 | 2020-07-03 | 荆楚理工学院 | Traditional Chinese medicine electric aromatherapy liquid with epidemic prevention function and preparation method and application thereof |
Non-Patent Citations (4)
| Title |
|---|
| 卢晓燕，等: "芳香化浊液空气净化作用研究", 《新中医》 * |
| 湖北省卫生计生宣传教育中心，等: "《新冠肺炎防控科普指南》", 28 February 2020, 湖北科学技术出版社 * |
| 王慧: "《中药养生300问》", 31 December 2015, 第二军医大学出版社 * |
| 韩平，等: "《甲型H1N1流感中医药防治问答》", 28 February 2010, 人民军医出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103444801B (en) | The pure and fresh preparation of a kind of library's sterilization Chinese medicine sterilizing | |
| CN105664215B (en) | A kind of pure Chinese medicine vehicle air freshener and preparation method thereof | |
| Sonibare et al. | Ethnobotanical survey of anti-asthmatic plants in South Western Nigeria | |
| CN103585540B (en) | Incense-fumigating oil of rhizoma atractylodis and folium artemisiae argyi | |
| CN103110310A (en) | Traditional Chinese medicine health-caring health maintaining pillow | |
| CN105456865B (en) | Traditional Chinese medicine bag for odor therapy, preparation method thereof and traditional Chinese medicine odor therapy device | |
| CN105031035A (en) | Medicine for treating rhinitis and preparation method of medicine | |
| CN101167804A (en) | Orally-administered traditional Chinese medicinal pill for treating halitosis | |
| CN107485081B (en) | A kind of preventing cold mask | |
| CN113116958A (en) | Traditional Chinese medicine sachet and preparation method thereof | |
| CN116139237B (en) | A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application | |
| CN113491751A (en) | A medicated core for preventing influenza, Chinese medicinal composition, sachet, medicated bath bag, foot bath bag, and preparation method thereof | |
| CN104888428A (en) | Mint-fragrant tennis racket having far-infrared biological therapeutic effect | |
| Zende et al. | Role of Ayurveda in prevention of Covid-19 pandemic-An Integrative Overview | |
| CN100464763C (en) | Chinese medicinal incense used for preventing infectious disease and its making method | |
| Zhang et al. | Application of traditional chinese aromatherapy in the prevention and treatment of COVID-19 | |
| CN1151808C (en) | Snuff xinnaokang for treating cardiovascular and cerebrovascular disease | |
| Kumaravel | Dhumapana: An effective Ayurvedic herbal smoking technique for prevention and treatment of COVID-19 like diseases | |
| CN108853178A (en) | A kind of children are healthy and strong draft bath powder and its preparation process | |
| CN215231206U (en) | Physiotherapeutic nose fumigating cigarette | |
| CN103920095A (en) | Traditional Chinese medicine spray for preventing respiratory infectious disease | |
| CN106343839A (en) | Health-care pillow with traditional Chinese medicine | |
| CN101317989B (en) | Pure traditional Chinese medicine medicament composition for treating white plague | |
| CN105767058A (en) | Air sanitizer capable of improving productive performance of ewes | |
| Agarwal et al. | Combing through traditional texts to prevent COVID-19-A scientific approach |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20211012 |